Skip to content

Author

S. Störk

We have 2 of 68 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Discordance between N-terminal pro-B-type natriuretic peptide and left ventricular end-diastolic pressure in suspected heart failure with a preserved ejection fraction: implications for diagnosis and prognosis.

BACKGROUND Diagnosing heart failure with preserved ejection fraction (HFpEF) remains challenging, as natriuretic peptides and resting haemodynamic measurements reflect complementary but incomplete aspects of myocardial stress and filling pressure. METHODS In this prospective all-comer cohort (UKSH-Trial registration...

Gülmisal Güder, S. Störk, Stefan Frantz et al. · 0 citations
Open access Sep 2026

Efficacy of Vericiguat by Background Guideline-Directed Medical Therapy in the VICTOR Trial.

In ambulatory patients with HFrEF receiving contemporary GDMT, it is not convincing evidence that the neutral effect of vericiguat on cardiovascular death or first HF hospitalization was modified by GDMT class, dose attainment, or overall intensity, in a cohort with very high background GDMT use and limited power for i...

Justin A. Ezekowitz, J. Butler, Derek Cyr et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.